Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A paper by Oxford BRC-supported researchers says that linking research funding to Athena SWAN gender equality action plans has been associated with a rise in the number of women in mid-level leadership positions and the proportion of funding going to women.

Female scientist in the lab © Medical Sciences Division and John Cairns

The paper, published in the BMJ, said that more funders should trial funding incentives as they have been shown to work. The research team was led by Pavel Ovseiko, Senior Research Fellow in the Radcliffe Department of Medicine.

To accelerate women’s advancement and leadership, the National Institute for Health Research (NIHR) in 2011 linked its research funding to the implementation by universities of gender equality action plans through the Athena SWAN (Scientific Women’s Academic Network) charter.

In the 2016 round of the competition, the NIHR said it would not shortlist any research centre where the academic partners had not achieved at least the Athena SWAN silver award.

After the introduction of the Athena SWAN incentives, the proportion of female theme leads in BRCs increased from 8%in both 2006 and 2011 to 24% in 2016. The proportion of women in senior director positions also increased, albeit more modestly, from 11% in 2006 and 10% in 2011 to 15% in 2016.

The full story is available on the NIHR Oxford Biomedical Research Centre website

Similar stories

Typhoid vaccine trial confirms sustained protection for older children

A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.